KR20000070260A - 아실화된 α-아미노 카르복시산 아미드의 제조방법 - Google Patents
아실화된 α-아미노 카르복시산 아미드의 제조방법 Download PDFInfo
- Publication number
- KR20000070260A KR20000070260A KR1019997006488A KR19997006488A KR20000070260A KR 20000070260 A KR20000070260 A KR 20000070260A KR 1019997006488 A KR1019997006488 A KR 1019997006488A KR 19997006488 A KR19997006488 A KR 19997006488A KR 20000070260 A KR20000070260 A KR 20000070260A
- Authority
- KR
- South Korea
- Prior art keywords
- aminonitrile
- carboxylic acid
- acyl halide
- acylated
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title description 2
- 125000005219 aminonitrile group Chemical group 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 21
- 150000001266 acyl halides Chemical class 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclo-pentanone Natural products O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 claims description 7
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical group CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 claims description 7
- 238000005917 acylation reaction Methods 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 230000010933 acylation Effects 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 150000001408 amides Chemical class 0.000 abstract description 6
- 238000001914 filtration Methods 0.000 abstract description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 3
- 150000002825 nitriles Chemical class 0.000 abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- -1 cycloleucine amides Chemical class 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001263 acyl chlorides Chemical class 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- KYQOPOVIDARNBM-UHFFFAOYSA-N 1-(pentanoylamino)cyclopentane-1-carboxamide Chemical compound CCCCC(=O)NC1(C(N)=O)CCCC1 KYQOPOVIDARNBM-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- YGVGITVCEHRBDK-UHFFFAOYSA-N 1-aminocyclopentane-1-carboxamide Chemical class NC(=O)C1(N)CCCC1 YGVGITVCEHRBDK-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Natural products CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical class 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/783,924 US5763661A (en) | 1997-01-17 | 1997-01-17 | Preparation of acylated α-amino carboxylic acid amides |
| US8/783,924 | 1997-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20000070260A true KR20000070260A (ko) | 2000-11-25 |
Family
ID=25130830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997006488A Withdrawn KR20000070260A (ko) | 1997-01-17 | 1997-12-22 | 아실화된 α-아미노 카르복시산 아미드의 제조방법 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6560349B1 (en) * | 1994-10-21 | 2003-05-06 | Digimarc Corporation | Audio monitoring using steganographic information |
| EP2194050A1 (en) | 2008-12-08 | 2010-06-09 | KRKA, tovarna zdravil, d.d., Novo mesto | A new process for the preparation of irbesartan |
| CN101704788B (zh) * | 2009-11-12 | 2011-09-07 | 苏州雅本化学股份有限公司 | 2-丁基-1,3-二氮杂螺环[4.4]壬烷-1-烯-4-酮的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| JPH04319932A (ja) * | 1991-04-19 | 1992-11-10 | Ricoh Co Ltd | 露光装置 |
| JPH06510762A (ja) * | 1991-08-19 | 1994-12-01 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | アンジオテンシン２受容体遮断イミダゾリノン誘導体 |
-
1997
- 1997-01-17 US US08/783,924 patent/US5763661A/en not_active Expired - Fee Related
- 1997-12-22 KR KR1019997006488A patent/KR20000070260A/ko not_active Withdrawn
- 1997-12-22 ES ES97953544T patent/ES2143446T1/es active Pending
- 1997-12-22 CA CA002269987A patent/CA2269987A1/en not_active Abandoned
- 1997-12-22 CN CN97181369A patent/CN1244857A/zh active Pending
- 1997-12-22 EP EP97953544A patent/EP0968176A4/en not_active Withdrawn
- 1997-12-22 JP JP53236698A patent/JP2001508455A/ja not_active Ceased
- 1997-12-22 WO PCT/US1997/024167 patent/WO1998031658A1/en not_active Application Discontinuation
- 1997-12-22 DE DE0968176T patent/DE968176T1/de active Pending
- 1997-12-22 BR BR9713725-1A patent/BR9713725A/pt unknown
- 1997-12-22 AU AU57270/98A patent/AU721099B2/en not_active Ceased
- 1997-12-24 TW TW086119728A patent/TW466227B/zh not_active IP Right Cessation
- 1997-12-30 IN IN3832DE1997 patent/IN187040B/en unknown
-
1998
- 1998-01-07 ZA ZA98114A patent/ZA98114B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0968176A1 (en) | 2000-01-05 |
| JP2001508455A (ja) | 2001-06-26 |
| US5763661A (en) | 1998-06-09 |
| IN187040B (enrdf_load_stackoverflow) | 2001-12-29 |
| WO1998031658A1 (en) | 1998-07-23 |
| CA2269987A1 (en) | 1998-07-23 |
| TW466227B (en) | 2001-12-01 |
| EP0968176A4 (en) | 2002-04-17 |
| ZA98114B (en) | 1998-07-08 |
| ES2143446T1 (es) | 2000-05-16 |
| CN1244857A (zh) | 2000-02-16 |
| AU721099B2 (en) | 2000-06-22 |
| AU5727098A (en) | 1998-08-07 |
| DE968176T1 (de) | 2001-01-11 |
| BR9713725A (pt) | 2000-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101719011B1 (ko) | (1ｓ, 2ｒ)-밀나시프란 합성 방법 | |
| RU1797607C (ru) | Способ получени /S/- @ -этил-2-оксо-1-пирролидинацетамида | |
| US4596885A (en) | Process for the preparation of phenylglyoxylic acid esters | |
| KR20000070260A (ko) | 아실화된 α-아미노 카르복시산 아미드의 제조방법 | |
| JP3054163B2 (ja) | ホスフィン酸エステル含有ｎ―アシル―２―アミノ酸アミド、その製造方法および前駆体としてのｎ―アシル―２―アミノ酸ニトリル | |
| AU617197B2 (en) | Process for the synthesis of optically active aminoacids | |
| JPS62289549A (ja) | Ｎ−（α−アルコキシエチル）−カルボン酸アミドの製造方法 | |
| MXPA99006217A (en) | PREPARATION OF ACYLATED&agr;-AMINO CARBOXYLIC ACID AMIDES | |
| JP2004524339A (ja) | 環状アミノ酸の調製方法 | |
| SU526285A3 (ru) | Способ получени производных 3-и/или 2-бутеновой кислоты | |
| JPH10195064A (ja) | ５−アミノ−１，２，４−チアジアゾール酢酸誘導体（シン異性体）の製造方法 | |
| KR100668111B1 (ko) | 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법 | |
| JP3216673B2 (ja) | ３−ヒドロキシイソオキサゾールの製造法 | |
| KR100413172B1 (ko) | 퀴놀리논 유도체의 제조방법 | |
| KR20000070259A (ko) | α-아미노 카르복시산 아미드의 제조방법 | |
| US20110112309A1 (en) | Preparation process useful in synthesis of atorvastatin | |
| US7094928B2 (en) | Process for the synthesis of (±) 2-Amino-N-[2,(2,5-dimethoxy phenyl)-2-hydroxyethyl] acetamide monohydrochloride | |
| KR100994548B1 (ko) | 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 및 그의 제조방법 | |
| JPH07285921A (ja) | ２−アミノ−Ｎ−（β−ヒドロキシフェネチル）アセトアミド誘導体の製造方法 | |
| FR2497797A1 (fr) | Procede de preparation de l'amino-4 butyramide | |
| KR20090010546A (ko) | 가바펜틴의 제조 방법 및 중간체 | |
| JPH0114226B2 (enrdf_load_stackoverflow) | ||
| JP2000256337A (ja) | チオモルホリン類の製造方法 | |
| JPH0737429B2 (ja) | モノアリ−ルマロン酸アミド類の製造法 | |
| JPH0114227B2 (enrdf_load_stackoverflow) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19990716 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |